+1 (514) 257-3003 info@cra-school.com
 

The unique Medicago plant-based Covid-19 Canadian vaccine

Clinical Safety & Pharmacovigilance during product life cycle

 

Key concepts of pharmacovigilance throughout the medical product development cycle and clinical safety of the unique Medicago’s plant-based vaccine against COVID-19.

 

             June 21, Monday, 4:00 pm EST

 

Speaker: Dr Asif Mahmood, MD, MPH, MBA, Chief Safety Officer

               VP Global Clinical Safety at Medicago

 

Host:       Bersabeh Bouramand, PharmD, MBA,

                Clinical Affairs Liaison, CRA School Montreal

 

The Medicago vaccine is currently in end-Phase III clinical trial. Despite his extremely overcharged schedule, Dr Mahmood generously agreed to spare some of his time to speak to aspiring clinical research professionals. We are very grateful for his altruism.

Free event. Recording available if busy at that hour